Dr. Sahin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161Fax+1 713-745-5709
Summary
- Dr. Aysegul Sahin is a pathologist in Houston, TX and is affiliated with University of Texas M.D. Anderson Cancer Center. She received her medical degree from Ankara University Faculty of Medicine and has been in practice 37 years. She specializes in anatomic pathology, clinical pathology, and surgical pathology.
Education & Training
University of Texas Health Science Center at HoustonResidency, Pathology-Anatomic and Clinical, 1987 - 1988
University of Iowa Hospitals and ClinicsResidency, Pathology-Anatomic and Clinical, 1986 - 1987
Oregon Health & Science University (OHSU Health)Residency, Pathology-Anatomic and Clinical, 1982 - 1986
Ankara University FOMClass of 1980
Certifications & Licensure
OR State Medical License 1984 - Present
TX State Medical License 1988 - 2025
AK State Medical License 1985 - 1990
American Board of Pathology Anatomic Pathology & Clinical Pathology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2010-2014
- Top Doctors:SE Texas Castle Connolly, 2013
- America's Top Doctors for Cancer Castle Connolly, 2009-2013
Publications & Presentations
PubMed
- Classification of fibroepithelial lesions of the breast in core needle biopsy with implications for further management.Emad A Rakha, Cecily Quinn, Wendy Raymond, Kimberly H Allison, Sunil S Badve
Modern Pathology. 2025-02-11 - Accumulation of CD38 in Hybrid Epithelial/Mesenchymal Cells Promotes Immune Remodeling and Metastasis in Breast Cancer.Tanvi H Visal, Recep Bayraktar, Petra den Hollander, Michael A Attathikhun, Tieling Zhou
Cancer Research. 2025-01-24 - Human Epidermal Growth Factor Receptor 2 Loss Following Treatment with Trastuzumab Deruxtecan in Patients with Metastatic Breast Cancer.Mohamed A Gouda, Amrit Gonugunta, Ecaterina E Dumbrava, Timothy A Yap, Jordi Rodon
Clinical Cancer Research. 2025-01-22
Journal Articles
- Multidisciplinary Intraoperative Assessment of Breast Specimens Reduces Number of Positive MarginsK K Hunt, A S Caudle, H B Neuman, I Bedrosian, S M DeSnyder, D M Black, H M Kuerer, A A Sahin, Annals of Surgical Oncology
Press Mentions
Texas Childcare Facilities Thrown into Chaos Amid Coronavirus CrisisJuly 24th, 2020
Grant Support
- Multidisciplinary Subspecialty Pathology Research Fellowship ProgramNational Cancer Institute2011
- Tissue Procurement And Pathology CoreNational Cancer Institute2008–2009
- Core--Pathology And TissueNational Cancer Institute2001–2002
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
